Cbd Oil

Verify with FDA CVM →

89 adverse event reports submitted to the FDA

Important: Adverse event reports do not establish that a drug caused or contributed to the event. Consult your veterinarian before making treatment decisions.
89
Total Reports
17
Deaths Reported
1910.0%
Death Rate

Active Ingredients

Cbd Oil

Administration Routes

OralUnknown

Species Affected

Dog 82
Cat 7

Most Affected Breeds

Retriever - Labrador 8
Terrier - Bull - American Pit 7
Chihuahua 4
Bulldog 4
Domestic Shorthair 4
Crossbred Canine/dog 4
Spaniel - King Charles Cavalier 3
Cattle Dog - Australian (blue heeler, red heeler, Queensland cattledog) 3
Shepherd Dog - Australian 3
Terrier - Yorkshire 2

Most Reported Reactions

Vomiting 15
Death by euthanasia 13
Seizure NOS 13
Not eating 10
Diarrhoea 9
Lethargy (see also Central nervous system depression in 'Neurological') 8
Inappropriate urination 8
Limb weakness 7
Weight loss 6
Lack of efficacy - NOS 6
Panting 6
Elevated serum alkaline phosphatase (SAP) 5

Outcome Breakdown

Outcome Unknown
29 (32.6%)
Ongoing
28 (31.5%)
Recovered/Normal
15 (16.9%)
Euthanized
13 (14.6%)
Died
4 (4.5%)

Data Summary

Metric Value
Total adverse event reports 89
Reports involving death 17
Case-fatality rate (reported events) 1910.0%
Distinct species in reports 2
Distinct breeds in reports 20
Distinct reactions reported 20
Active ingredients on file 1

Source: FDA Center for Veterinary Medicine — Adverse Event Reporting (CVM AER). Counts reflect voluntary reports only.

Cbd Oil Adverse Event Insights

The FDA Center for Veterinary Medicine database currently holds 89 adverse event reports referencing Cbd Oil, including 17 reports in which the animal died — a 1910.0% case-fatality figure among reported events only, not a population-level mortality rate. Active ingredient on file: Cbd Oil. Reported administration routes include Oral, Unknown. These numbers reflect voluntary submissions from pet owners, veterinarians, and manufacturers and therefore under-represent mild events and over-represent severe ones — a pattern the FDA has documented repeatedly for pharmacovigilance datasets.

The species most frequently named in Cbd Oil reports are Dog (82 reports), Cat (7 reports), with Dog accounting for the largest share. Within those species, Retriever - Labrador (8), Terrier - Bull - American Pit (7), Chihuahua (4) appear most often — though breed popularity and ownership density shape these counts as much as any drug-specific sensitivity. This distribution matters because the same active ingredient can behave very differently across body sizes, ages, and species physiology.

The most commonly reported clinical signs associated with Cbd Oil are Vomiting (15), Death by euthanasia (13), Seizure NOS (13), Not eating (10). Of the 89 reports with a coded outcome, Outcome Unknown is the leading category at 32.6%. Because FDA adverse event data describes correlation rather than causation, these figures are best used to frame informed questions with a veterinarian and to compare reporting patterns across related products — not as a standalone safety verdict on Cbd Oil.

Source: FDA Center for Veterinary Medicine — Adverse Event Reports FDA Center for Veterinary Medicine — Adverse Event Reports Data reflects voluntary submissions and may not represent actual incidence rates

Related

Data sourced from official AKC, AVMA, ACVO, and breed-club veterinary references. See our methodology for details. Retrieved and formatted by PlainBreed Editorial